| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | Director | Common Stock | 15.1K | $452K | $30.00 | May 29, 2025 | Direct |
| Prime Medicine, Inc. | Chief Business Officer | Common Stock | 20K | $23.8K | $1.19 | May 20, 2025 | Direct |
| VOLITIONRX LTD | Director | Common Stock | 27.9K | $23.2K | $0.83 | Jan 12, 2023 | Direct |
| Prime Medicine, Inc. | Chief Business Officer | Stock Option (right to buy) | 225K | Feb 27, 2025 | Direct | ||
| Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | Restricted Stock Units | 16.3K | Feb 16, 2022 | Direct | ||
| Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | Stock Option (Right to Buy) | 10.9K | Feb 16, 2022 | Direct | ||
| Scholar Rock Holding Corp | Director | Stock Option (Right to Buy) | 9.21K | May 22, 2025 | Direct | ||
| VOLITIONRX LTD | Director | Stock Option (Right to Buy) | 8.64K | Jun 23, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | May 29, 2025 | 2 | -$181K | 4 | May 30, 2025 | Director |
| SRRK | Scholar Rock Holding Corp | May 22, 2025 | 2 | $0 | 4 | May 23, 2025 | Director |
| PRME | Prime Medicine, Inc. | May 20, 2025 | 1 | $23.8K | 4 | May 22, 2025 | Chief Business Officer |
| PRME | Prime Medicine, Inc. | Feb 27, 2025 | 1 | $0 | 4 | Mar 3, 2025 | Chief Business Officer |
| PRME | Prime Medicine, Inc. | Dec 5, 2024 | 1 | $0 | 4 | Dec 9, 2024 | Chief Business Officer |
| SRRK | Scholar Rock Holding Corp | Jun 27, 2024 | 2 | $0 | 4 | Jul 1, 2024 | Director |
| PRME | Prime Medicine, Inc. | May 17, 2024 | 1 | $0 | 4 | May 21, 2024 | Chief Business Officer |
| PRME | Prime Medicine, Inc. | Feb 21, 2024 | 1 | $0 | 4 | Feb 23, 2024 | Chief Business Officer |
| SRRK | Scholar Rock Holding Corp | Apr 6, 2023 | 1 | $0 | 4 | Apr 10, 2023 | Director |
| SRRK | Scholar Rock Holding Corp | Apr 6, 2023 | 0 | $0 | 3 | Apr 10, 2023 | Director |
| PRME | Prime Medicine, Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Business Officer |
| VNRX | VOLITIONRX LTD | Jan 12, 2023 | 1 | $0 | 4 | Jan 13, 2023 | Director |
| PRME | Prime Medicine, Inc. | Oct 19, 2022 | 0 | $0 | 3 | Oct 19, 2022 | Chief Business Officer |
| VNRX | VOLITIONRX LTD | Oct 13, 2022 | 1 | $0 | 4 | Oct 14, 2022 | Director |
| VNRX | VOLITIONRX LTD | Jun 23, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
| VNRX | VOLITIONRX LTD | Apr 7, 2022 | 2 | $0 | 4 | Apr 8, 2022 | Director |
| CDAKQ | Codiak BioSciences, Inc. | Feb 16, 2022 | 2 | $0 | 4 | Feb 18, 2022 | Officer title: Chief Business Officer and Head of Corporate Strategy |
| CDAKQ | Codiak BioSciences, Inc. | Jan 19, 2022 | 2 | $0 | 4 | Jan 21, 2022 | Officer title: Chief Business Officer and Head of Corporate Strategy |